A Comparison of Three Chemotherapy Regimens for the Treatment of Patients With Newly Diagnosed Mantle Cell Lymphoma

NCT04115631 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

360

Enrollment

NETWORK

Sponsor class

Conditions

Liver Lymphoma
Mantle Cell Lymphoma

Interventions

DRUG: Acalabrutinib
DRUG: Bendamustine
DRUG: Bendamustine Hydrochloride
DRUG: Cytarabine
BIOLOGICAL: Rituximab

Sponsor

ECOG-ACRIN Cancer Research Group

Collaborators

[object Object]